Home/Filings/4/0001415889-24-017842
4//SEC Filing

Campbell Shannon 4

Accession 0001415889-24-017842

CIK 0001701541other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:20 PM ET

Size

5.3 KB

Accession

0001415889-24-017842

Insider Transaction Report

Form 4
Period: 2024-06-21
Transactions
  • Award

    Common Stock

    2024-06-21$4.98/sh+2,011$10,0152,011 total
Footnotes (2)
  • [F1]These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 20, 2024.

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

Related Parties

1
  • filerCIK 0002018966

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:20 PM ET
Size
5.3 KB